51 research outputs found

    Competition and Combative Advertising: An Historical Analysis

    Get PDF
    Fred K. Beard (PhD, University of Oklahoma) is a professor of advertising in the Gaylord College of Journalism and Mass Communication, University of Oklahoma. His research interests include comparative advertising, advertising humor, and advertising history. His work has appeared in the Journal of Advertising, the Journal of Advertising Research, the Journal of Business Ethics, the Journal of Business Research, Journalism History, the Journal of Historical Research in Marketing, the Journal of Macromarketing, and the Journal of Marketing Communications, among others.Yeshttps://us.sagepub.com/en-us/nam/manuscript-submission-guideline

    Effects of a Commercial Herbal-Based Formula on Exercise Performance in Cyclists

    No full text
    Introduction/Purpose: We examined the effects of a commercially marketed herbal-based formula purported to increase endurance on oxygen consumption (V̇O2) in 17 competitive category III/IV amateur cyclists [mean (SEM) age: 31.1 (1.8) yr; height: 178.5 (1.8) cm; weight: 77.1 (1.6) kg]. Methods: Each cyclist participated in two (pre/post) cycling tests progressing 25 W·4 min-1 starting at 100 W administered in a randomized, placebo-controlled, double-blind fashion. The second trial was performed 14 d after the ingestion of a manufacturer recommended loading phase (4 d × 6 caps·d-1) and a maintenance phase (11 d × 3 caps·d-1). Three treatment capsules contained 1000 mg of Cordyceps sinensis (CS-4) and 300 mg Rhodiola rosea root extract as the primary ingredients; 800 mg of other ingredients included calcium pyruvate, sodium phosphate, potassium phosphate, ribose, and adenosine and 200 mcg of chromium. Results: Using a 2 × 2 ANOVA, we observed no significant treatment effect for any between or within group variables including peak V̇O2 [treatment 4.14 (0.2) L·min-1; placebo 4.10 (0.2) L·min-1], time to exhaustion [treatment 38.47 (1.7) min; placebo 36.95 (1.8) min], peak power output (PO) [treatment 300.00 (12.1) W; placebo 290.63 (12.9) W], or peak heart heart rate. We also observed no differences for any subpeak exercise variable including the PO eliciting 2 mmol·L-1 blood lactate (BLa) [treatment 201.00 (18.1) W; placebo 167.50 (19.2) W] and 4 mmol·L-1 BLa [treatment 235.88 (15.8) W; placebo 244.78 (14.9) W], ventilatory threshold, respiratory compensation point, or V̇O2 L·min-1 and gross efficiency at each stage, Conclusion: A 2-wk ingestion schema of a commercial herbal-based formula is insufficient to elicit positive changes in cycling performance.Sin financiación2.525 JCR (2004) Q1, 3/71 Sport sciencesUE
    corecore